Prevention of cholera
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
The prevention of cholera is based on a system of measures aimed at preventing the introduction of infection from endemic foci. Of great importance are the identification of patients and vibrio carriers, their timely isolation and sanitation from the pathogen. Localization and elimination of the focus of infection presume a system of quarantine measures, including isolation and examination of persons in contact with the patient, and provisional admission of all diarrheal diseases in the outbreak.
To create active immunity, a cholera vaccine is used - the cholera vaccine is a bivalent chemical tableted vaccine, which is a mixture of the cholerogen-toxoid in the bacillary cultures of cholera vibrios Inaba and Ogawa. Vaccination is carried out according to epidemiological indications. Dose of vaccine:
- for children 2-10 years - 1 tablet,
- for adolescents 11-17 years - 2 tablets,
- for adults - 3 tablets once for 1 hour before meals. Revaccination is carried out 6-7 months after the initial vaccination.
[